Biomarkers May Predict Better Immunotherapy Treatment Outcomes for Certain Patients with Pancreatic Cancer
SAN FRANCISCO--(BUSINESS WIRE)-- #ASCO22--Findings in pancreatic cancer study from Parker Institute for Cancer Immunotherapy researchers presented at ASCO and published in Nature Medicine.
